심장재동기화치료 시장 규모, 점유율, 동향 분석 : 제품별(CRT-제세동기, CRT-페이스메이커), 최종사용자별(병원, 심장 센터, 기타), 지역별, 부문별 예측(2023-2030년)

Cardiac Resynchronization Therapy Market Growth & Trends:

The global cardiac resynchronization therapy market size is anticipated to reach USD 6.23 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 4.8% from 2023 to 2030. The key factors driving the market growth include growing initiatives by key companies, rising product advancements, and increasing product adoption by end users

The CRT market was significantly impacted by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include demand slowdown, fall in sales, and supply chain disruption due to the cancellation of operational hurdles and elective procedures. For instance, Abbott, one of the major players in the cardiac rhythm management device business, reported a decline in revenue growth of the cardiovascular business in 2020. Boston Scientific has reported a decline in sales across all regions in 2020. By Q3 2021, the company's sales recovered gradually with the cardiac rhythm management segment accounting for USD 1.5 billion in total revenue.

Furthermore, COVID-19 had a negative impact on Medtronic's fourth-quarter financial performance, which ended on April 24, 2020. Postponed elective and semi-elective treatments using Medtronic devices had an impact on the corporation. People's reluctance to undertake non-COVID-19 emergency procedures has an impact on the company's emerging product lines. By 2021, the company's sales had returned to positive territory. Its cardiac & rhythm management portfolio revenues increased by 11% year on year for the six months ending in October 2021.

Increasing product advancements and initiatives by key market players are expected to propel market growth in the coming years. For instance, in February 2020, Medtronic received the CE mark clearance for its cardiac resynchronization therapy defibrillators (CRT-Ds) combined with smart features such as AdaptivCRT and EffectivCRT algorithms. Similarly, in July 2020, Abbott received approval from the US FDA for its cardiac resynchronization therapy defibrillator (CRT-D) devices equipped with Bluetooth features.

Cardiac Resynchronization Therapy Market Report Highlights:

• The Cardiac Resynchronization Therapy market was valued at USD 4.26 billion in 2022 and is expected to grow at a CAGR of 4.8% during the forecast period

• Rapid technological advancements are one of the key trends escalating market growth. The adoption of a sedentary lifestyle, the growing geriatric population along with the increasing prevalence of cardiovascular diseases is also stimulating the growth of the market

• CRT-D segment dominated the market by product in 2022, owing to the high adoption of these devices, wider applications, and growing prevalence of cardiovascular diseases

• CRT-P held a notable share of the market in 2022 and is projected to grow at the fastest rate over the forecast period. This is owing to growing indications and the high prevalence of heart failure across the globe

• The hospitals' segment held the largest market share of over 52.08% in 2022, as these centers are the main point of care for CRT device installation after diagnosis

• North America held the largest market share of over 49.9% in 2022, owing to the well-established healthcare system, and per capita, healthcare spending in this region is expected to fuel the market growth over the forecast period

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research:
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
• 1.7 List Of Secondary Sources
• 1.8 Report Objectives

Chapter 2 Executive Summary

• 2.1 Cardiac Resynchronization Therapy (CRT) Market Outlook, 2018 - 2030 (USD Million)
• 2.2 Cardiac Resynchronization Therapy (CRT) Market Summary, 2022

Chapter 3 Cardiac Resynchronization Therapy (CRT) Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Cardiac Resynchronization Therapy (CRT) Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Increasing Prevalence Of Cardiovascular Diseases
    • 3.3.1.2 Technological Advancements
    • 3.3.1.3 Rising Sedentary Lifestyle
    • 3.3.1.4 Increasing Geriatric Population
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 Product Recall
    • 3.3.2.2 High Cost Of Device
• 3.4 Regulatory Framework
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 APAC
  • 3.4.4 LATAM
  • 3.4.5 MEA
• 3.5 Cardiac Resynchronization Therapy (CRT) Market Analysis Tools
  • 3.5.1 Industry Analysis - Porter's
    • 3.5.1.1 Bargaining Power Of Suppliers: Low
    • 3.5.1.2 Bargaining Power Of Buyers: Low
    • 3.5.1.3 Threat Of Substitutes: High
    • 3.5.1.4 Threat Of New Entrants: Low
    • 3.5.1.5 Competitive Rivalry: Moderate
  • 3.5.2 Cardiac Resynchronization Therapy (CRT)- Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 3.5.2.1 Political & Legal Landscape
    • 3.5.2.2 Economic Landscape
    • 3.5.2.3 Social Landscape
    • 3.5.2.4 Technology Landscape
• 3.6 U.S. Cardiac Resynchronization Therapy Procedure Code List
  • 3.6.1 CPT Codes List For Initial, Upgrade, And Replacement CRT System Implant
  • 3.6.2 ICD-10-Pcs Codes For Initial, Upgrade, And Replacement CRT System Implant
• 3.7 Global Cardiac Resynchronization Therapy (CRT) Market, Asp, By Region 2018 - 2030 (USD)
  • 3.7.1 Global CRT-Defibrillator, Asp, By Region 2018 - 2030 (USD)
  • 3.7.2 Global CRT-Pacemaker, Asp, By Region 2018 - 2030 (USD)
• 3.8 Global Cardiac Resynchronization Therapy (CRT) Market, Unit Volume, By Region 2018 - 2030 (USD)
  • 3.8.1 Global CRT-Defibrillator, Unit Volume, By Region 2018 - 2030 (USD)
  • 3.8.2 Global CRT-Pacemaker, Unit Volume, By Region 2018 - 2030 (USD)
• 3.9 Covid-19 Impact Analysis
  • 3.9.1 Covid-19 Impact And Future Scenario
  • 3.9.2 Impact On Market Players
    • 3.9.2.1 Factors And Strategies, By The Competitor

Chapter 4 Cardiac Resynchronization Therapy (CRT) Market: Product Estimates & Trend Analysis

• 4.1 Product Market Share Analysis, 2022 & 2030
• 4.2 Product Dashboard
• 4.3 CRT-D
  • 4.3.1 CRT-D Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.4 CRT-P
  • 4.4.1 CRT-P Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Cardiac Resynchronization Therapy (CRT) Market: End-Use Estimates & Trend Analysis

• 5.1 End-Use Market Share Analysis, 2022 & 2030
• 5.2 End-Use Dashboard
• 5.3 Hospital
  • 5.3.1 Hospital Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.4 Cardiac Centers
  • 5.4.1 Cardiac Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5 Others
  • 5.5.1 Other End-Users Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Cardiac Resynchronization Therapy (CRT) Market: Regional Estimates & Trend Analysis, By Product, And End-Use

• 6.1 Regional Market Snapshot
• 6.2 Region Market Share Analysis, 2022 & 2030
• 6.3 North America
  • 6.3.1 North America Cardiac Resynchronization Therapy (CRT) Market Estimates And Orecasts, 2018 - 2030 (USD Million)
  • 6.3.2 U.S.
    • 6.3.2.1 U.S. Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3 Canada
    • 6.3.3.1 Canada Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4 Europe
  • 6.4.1 Europe Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2 UK
    • 6.4.2.1 UK Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.3 Germany
    • 6.4.3.1 Germany Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.4 France
    • 6.4.4.1 France Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.5 Italy
    • 6.4.5.1 Italy Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.6 Spain
    • 6.4.6.1 Spain Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5 Asia Pacific
  • 6.5.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2 JAPAN
    • 6.5.2.1 Japan Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3 China
    • 6.5.3.1 China Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4 India
    • 6.5.4.1 India Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.5 Australia
    • 6.5.5.1 Australia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.6 South Korea
    • 6.5.6.1 South Korea Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6 Latin America
  • 6.6.1 Latin America Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2 Mexico
    • 6.6.2.1 Mexico Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3 Brazil
    • 6.6.3.1 Brazil Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4 Argentina
    • 6.6.4.1 Argentina Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7 Middle East & Africa (MEA)
  • 6.7.1 MEA Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2 South Africa
    • 6.7.2.1 South Africa Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3 Saudi Arabia
    • 6.7.3.1 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.4 UAE
    • 6.7.4.1 UAE Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

• 7.1 Company Profiles
  • 7.1.1 ABBOTT
    • 7.1.1.1 Company overview
    • 7.1.1.2 Product benchmarking
    • 7.1.1.3 Financial performance
    • 7.1.1.4 Strategic initiatives
  • 7.1.2 BOSTON SCIENTIFIC CORPORATION
    • 7.1.2.1 Company overview
    • 7.1.2.2 Product benchmarking
    • 7.1.2.3 Financial performance
    • 7.1.2.4 Strategic initiatives
  • 7.1.3 MEDTRONIC
    • 7.1.3.1 Company overview
    • 7.1.3.2 Product benchmarking
    • 7.1.3.3 Financial performance
    • 7.1.3.4 Strategic initiatives
  • 7.1.4 BIOTRONIK SE & CO. KG
    • 7.1.4.1 Company overview
    • 7.1.4.2 Product benchmarking
    • 7.1.4.3 Financial performance
    • 7.1.4.4 Strategic initiatives
  • 7.1.5 MICROPORT SCIENTIFIC CORPORATION
    • 7.1.5.1 Company overview
    • 7.1.5.2 Product benchmarking
    • 7.1.5.3 Financial performance
    • 7.1.5.4 Strategic initiatives
  • 7.1.6 Livanova plc.
    • 7.1.6.1 Company overview
    • 7.1.6.2 Product benchmarking
    • 7.1.9.3 Financial performance
    • 7.1.6.4 Strategic initiatives
• 7.2 Market Participation Categorization
  • 7.7.1 Company Market Position Analysis
• 7.3 Major Deals & Strategic Alliances Analysis